What is PERK Plastic Surgery?
Led by Dr. Michelle Lee, a board-certified plastic surgeon, PERK Plastic Surgery operates at the intersection of advanced clinical expertise and patient-centric aesthetic care. The practice distinguishes itself through a specialized focus on aesthetic and reconstructive breast surgery, alongside sophisticated facial rejuvenation techniques. Furthermore, the firm has carved out a unique niche in the surgical treatment of migraines, demonstrating a commitment to both cosmetic enhancement and functional medical outcomes. This dual-focus approach allows the organization to maintain a high-authority position in the medical aesthetics landscape, catering to a diverse patient demographic seeking both restorative and elective surgical interventions.
How much funding has PERK Plastic Surgery raised?
PERK Plastic Surgery has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PERK Plastic Surgery
PPP
Public-Private Partnership
What's next for PERK Plastic Surgery?
With the successful closure of this late-stage financing, PERK Plastic Surgery is poised to accelerate its strategic initiatives. The capital will likely be deployed toward scaling clinical capacity, enhancing surgical technology integration, and potentially expanding the practice's footprint to meet the rising demand for specialized reconstructive and aesthetic procedures. As the organization transitions into this next phase of development, the focus will remain on maintaining clinical excellence while optimizing patient acquisition and retention strategies. The firm's ability to secure such substantial backing reflects investor confidence in its long-term viability and its capacity to lead in the evolving field of surgical rejuvenation.
See full PERK Plastic Surgery company page
